Atyr Pharma Inc (ATYR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2017 | 12-2016 | 09-2016 | 06-2016 | 03-2016 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -13,405 | -57,855 | -45,289 | -31,470 | -16,087 |
| Depreciation Amortization | 337 | 1,604 | 1,305 | 951 | 551 |
| Other Working Capital | -2,016 | -1,353 | -825 | 1,541 | 1,841 |
| Other Operating Activity | 1,196 | 4,743 | 3,643 | 2,499 | 1,204 |
| Operating Cash Flow | $-13,888 | $-52,861 | $-41,166 | $-26,479 | $-12,491 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 4,661 | 34,127 | 25,479 | 18,727 | 14,706 |
| PPE Investments | -262 | -600 | -554 | -490 | -314 |
| Investing Cash Flow | $4,399 | $33,527 | $24,925 | $18,237 | $14,392 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | 9,736 | N/A | N/A | N/A |
| Debt Repayment | N/A | -5,202 | N/A | N/A | N/A |
| Common Stock Issued | 1 | 163 | 95 | 94 | 11 |
| Other Financing Activity | 0 | 0 | -2,547 | -1,686 | -838 |
| Financing Cash Flow | $1 | $4,697 | $-2,452 | $-1,592 | $-827 |
| Beginning Cash Position | 38,388 | 53,025 | 53,025 | 53,025 | 53,025 |
| End Cash Position | 28,900 | 38,388 | 34,332 | 43,191 | 54,099 |
| Net Cash Flow | $-9,488 | $-14,637 | $-18,693 | $-9,834 | $1,074 |
| Free Cash Flow | |||||
| Operating Cash Flow | -13,888 | -52,861 | -41,166 | -26,479 | -12,491 |
| Capital Expenditure | -262 | -600 | -554 | -490 | -314 |
| Free Cash Flow | -14,150 | -53,461 | -41,720 | -26,969 | -12,805 |